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Mycobacterium tuberculosis serine/threonine protein kinases (STPKs) are key regulators of
growth and metabolism; however, evidence for their roles in virulence is limited. In a preliminary
screen based on comparative expression between strains H37Rv and H37Ra, six STPK genes,
pknD, pknG, pknH, pknJ, pknK and pknL, showed higher expression in H37Rv. In the second
screen, STPK expression was analysed in H37Rv-infected human macrophages. Interestingly,
significant expression of pknK was detected only at 18 h post-infection, suggesting its
involvement in early infection events. We have investigated the roles of PknK in vitro and in vivo.
PknK levels were induced under stationary phase and deletion of pknK resulted in increased
resistance of the mutant to acidic pH, hypoxia, oxidative and stationary-phase stresses in vitro.
These results, together with the increased survival of the DpknK strain during persistent infection
in mice, reveal a role for PknK in adaptive mechanisms that slow the growth of mycobacteria. A
novel finding of this study was the inhibition of growth of DpknK strain during acute infection in
mice that correlated with the significant upregulation of tumour necrosis factor as well as the
simultaneous downregulation of interleukin-12p40, interferon-c and induced nitric oxide synthase
transcripts. Finally, we provide evidence for the localization of PknK during infection and discuss
its implications in pathogenesis.
INTRODUCTION
Historically, tuberculosis has been a serious infectious
disease, with significant adverse effects on the human
population, and it remains so even today. A hallmark of the
disease is the ability of Mycobacterium tuberculosis to persist
in the host for years and to reactivate under conditions of
immune suppression. The situation is worsened by the
increasing incidence of multi-drug-resistant strains. It is
therefore imperative to identify novel M. tuberculosis
antigens/targets for the development of new effective
anti-tubercular drugs and vaccines.
The success of M. tuberculosis in establishing a niche inside
the host resides primarily in its adaptability to the
macrophage environment and evasion of the host defence
system. Recent studies on phospho-serine/threonine/tyr-
osine protein signalling in bacteria have established a role
for these proteins as key components of distinct, but well-
coordinated, signal transduction pathways regulating host–
pathogen interactions and intracellular survival (Cozzone,
2005; Zhang et al., 1992). These kinases are capable of
transducing subtle changes in the environment, both
intracellular and extracellular, by the rapid phosphoryla-
tion of several cellular proteins, specifically on serine/
threonine or tyrosine residues. M. tuberculosis possesses 11
‘eukaryotic-like’ STPKs (PknA–L) and one tyrosine kinase
(Av-Gay & Everett, 2000; Bach et al., 2009; Cole et al.,
1998). Of these, nine are transmembrane proteins and are
classified in three groups (PknA/B/L, PknF/I/J, PknD/E/H),
Abbreviations: ADS, albumin-dextrose-saline; BCG, Bacillus Calmette-
Gue ´rin; Ct, cycle threshold; HRP, horseradish peroxidase; IEM,
immunoelectron microscopy; IFN, interferon; IL, interleukin; iNOS,
inducible nitric oxide synthase; Mtb, Mycobacterium tuberculosis; qRT-
PCR, quantitative RT-PCR; SCOTS, selective capture of transcribed
sequences; SEM, scanning electron microscopy; STPK, serine/threonine
protein kinase; TEM, transmission electron microscopy; TNF, tumour
necrosis factor.
A supplementary table of primers and two supplementary figures are
available with the online version of this paper.
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that closely resemble the eukaryotic STPKs (Av-Gay &
Everett, 2000; Narayan et al., 2007).
All mycobacterial STPKs have been biochemically char-
acterized, mostly by in vitro studies, in terms of their kinase
activity and the identification of cognate target proteins
(Chao et al., 2009; Greenstein et al., 2005; Jang et al., 2010).
Several studies have established that mycobacterial STPKs
regulate a variety of metabolic processes, including cell
shape and cell division (Chaba et al., 2002; Dasgupta et al.,
2006, Kang et al., 2005, 2008; Thakur & Chakraborti, 2006,
2008), sugar uptake (Deol et al., 2005), metabolic enzymes
(Molle et al., 2006; Veyron-Churlet et al., 2009), nitrogen
homeostasis (Cowley et al., 2004; O’Hare et al., 2008),
transcription (Cohen-Gonsaud et al., 2009; Greenstein
et al., 2007; Kumar et al., 2009; Park et al., 2008; Sharma
et al., 2006) and biofilm formation (Gopalaswamy et al.,
2008). Despite such extensive research, very little is known
about STPK expression and function during M. tuberculosis
growth and survival in human macrophages. Besides PknG
(Cowley et al., 2004), only PknH and PknI (Gopalaswamy
et al., 2009; Papavinasasundaram et al., 2005) have been
implicated in M. tuberculosis survival, adaptation and
growth in vivo. PknG is of particular interest since
the ectopic expression of Mtb- or BCG-PknG in
Mycobacterium bovis BCG, or non-pathogenic mycobac-
teria, promotes survival by inhibiting phagosome–lyso-
some fusion (Scherr et al., 2009; Tiwari et al., 2009;
Walburger et al., 2004); however, this is yet to be
demonstrated in M. tuberculosis. The possibility of myco-
bacterial STPKs interacting with host signalling proteins is
intriguing and will have a profound impact on our
understanding of the mechanisms of mycobacterial viru-
lence, persistence, and reactivation.
This study aimed to identify candidate STPK genes that
may be involved in the survival of mycobacteria in human
macrophages, and thus may contribute to the pathogen-
esis of the tubercle bacillus. Using a transcriptomic
approach in two separate preliminary screens, we analysed
the differential expression of the 11 STPK genes in M.
tuberculosis H37Rv (virulent) versus H37Ra (avirulent)
strains and during H37Rv infection in human macro-
phages. The screen identified six STPK genes, two of
which encode less well-characterized STPKs (PknK and L)
that showed higher levels of expression in H37Rv
compared to H37Ra and were also expressed during
infection. Because of its close resemblance to eukaryotic
kinases and its high expression during exponential growth
of H37Rv in culture and at 18 h post-infection in human
macrophages, we were specifically interested in investi-
gating the role of PknK in mycobacterial pathogenesis.
Our results implicate PknK in the regulation of
M. tuberculosis growth under in vitro stress conditions.
Further, we elucidate a role for PknK during infection in
mice and present evidence that PknK not only plays a key
role during early events of infection by modulating
host immunity, but also modulates the growth of
M. tuberculosis during the persistent phase of infection.
These findings identify PknK as a component of
mycobacterial signalling pathways regulating early and
late events in tuberculosis infection and have implications
in host–pathogen interactions.
METHODS
Bacterial strains, plasmids and culture conditions. Bacterial
strains and plasmids used in this study are listed in Table 1. E. coli
strains JM109 and HB101 were used as host strains for all molecular
manipulations. M. tuberculosis H37Rv and H37Ra strains were
analysed for differences in STPK gene expression. Mycobacterium
smegmatis mc
2155 was used for the isolation and propagation of
recombinant mycobacteriophage for mutagenesis of pknK.
E. coli cultures were grown in Luria–Bertani (LB) broth or on LB agar
plates at 37 uC. M. tuberculosis cultures were cultivated in
Middlebrook 7H9 medium (Difco) supplemented with 0.05%
Tween 80 (Tw) and ADS [0.5% albumin/0.2% dextrose (glucose)/
0.085% saline] (henceforth referred to as 7H9-Tw-ADS), or on
Middlebrook 7H10 agar plates at 37 uC. M. smegmatis cultures were
grown at 37 uC in Middlebrook 7H9 or LB medium supplemented
with 0.05% Tween 80 or on LB agar plates. For stress studies, M.
tuberculosis cultures (OD600 ~0.2–0.4) were harvested, washed with
7H9 basal medium, resuspended in 7H9-Tw-ADS medium whose pH
had been adjusted to 5.5 (acidic stress) or spiked with 5 mM
hydrogen peroxide (oxidative stress), and grown aerobically. For
hypoxia studies, M. tuberculosis cultures were grown in Dubos Tween-
Albumin medium (Difco) to OD600 ~0.6, diluted to starting OD600
~0.05 and subjected to hypoxia in sealed tubes as described previously
(Saini et al., 2004). Antibiotics were used at the following
concentrations (mgm l
21): ampicillin (Amp), 100; kanamycin (Kan),
25; hygromycin (Hyg), 150 or 100 for E. coli and mycobacteria,
respectively. Primer sequences used in this study are listed in
Supplementary Table S1, available with the online version of this
paper.
RNA isolation and quantitative RT-PCR (qRT-PCR). RNA
isolation and qRT-PCR were performed as described previously
(Malhotra et al., 2009). RNA (100 ng) was reverse-transcribed into
cDNA to serve as the template in a real-time PCR using gene-specific
primers (Supplementary Table S1) and SYBR green dye (Bio-Rad).
Expression analyses were performed with RNA from three independ-
ent experiments. For each experiment, the calculated cycle threshold
(Ct) of the test gene was normalized to the Ct of the internal control
16S rRNA gene (amplified from the same samples), before calculating
the fold change of the test samples using the iQ5 expression software
(Bio-Rad).
SCOTS analysis. For analysis of STPK gene expression during
H37Rv infection of human macrophages, selective capture of trans-
cribed sequences (SCOTS) (Graham & Clark-Curtiss, 1999) was
performed. Previously developed SCOTS-generated cDNA mixtures
(Graham & Clark-Curtiss, 1999) were used as probes for hybridiza-
tion with STPK genes. Briefly, all STPK genes were amplified and
cloned into pGEM-T Easy vector (Promega) to generate plasmids
pYA1537 through pYA1546, pYA1620 and pYA1621 (Table 1). For
pknA, pknH and pknK genes, fragments encoding C- and N-terminal
regions were amplified separately. Equal amounts of experimental and
control plasmid DNA (pSH276, pSH337, pSH317, pSH281 and
pSH334) (Haydel & Clark-Curtiss, 2004) were digested with
appropriate enzymes, resolved on an agarose gel and transferred
onto nylon membranes for hybridization with DIG-labelled cDNA
probe mixtures. Detection was done using anti-DIG antibody
V. Malhotra and others
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escent substrate (Roche). Based on intensity values, the expression of
genes was designated low (+), moderate (++/+++) or high
(++++).
Purification of PknK, generation of polyclonal anti-PknK
antibodies and immunoblot analysis. The pknK ORF (Rv3080c,
3333 bp) was amplified and cloned into pET SUMO expression
vector (Invitrogen) to generate plasmid pYA1556. Subsequently,
pYA1556 was transformed into E. coli BL21(DE3) to induce
expression. Recombinant PknK with an N-terminal 6xHis-SUMO
tag was purified from IPTG-induced cultures by affinity chromato-
graphy using the ProBond Ni-Chelating resin (Invitrogen) according
to the manufacturer’s instructions.
For antibody generation, 100 mg of purified PknK protein was
emulsified with Freund’s incomplete adjuvant (Sigma) and injected
subcutaneously into two New Zealand White rabbits. Rabbits were
given two booster injections at 3-week intervals and sera were
collected 10 days after the second boost. Equal amounts of M.
tuberculosis cell lysates, prepared as described previously (Malhotra
et al., 2009), were resolved on a 6 or 10% SDS-PAGE gel, transferred
onto a nitrocellulose membrane and immunoblotted with anti-PknK
antibodies (1:2500). Detection was done using anti-rabbit IgG-HRP
(1:10000, Sigma) and LumiGLO chemiluminescent substrate (KPL).
Construction of DpknK mutant and complemented mutant
strains of M. tuberculosis. The pknK (Rv3080c) gene was deleted in
M. tuberculosis H37Rv and replaced with a Hyg resistance cassette by
Table 1. Bacterial strains and plasmids used in this study
Strain/plasmid Description Source/reference
Strains
M. tuberculosis H37Rv Virulent laboratory strain ATCC*
M. tuberculosis H37Ra Avirulent laboratory strain CWRUD
M. smegmatis mc
2155 ept-1 AECOMd
E. coli HB101 F
–, D(gpt-proA)62 leuB6 glnV44 ara-14 galK2 lacY1
D(mcrC-mrr) rpsL20(Str
r) xyl-5 mtl-1 recA13 thi-1
UCSF§
E. coli JM109 e14
2 (McrA
2) recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 D(lac-proAB) Stratagene
E. coli BL21(DE3) F
–, ompT hsdSB (r{
B m{
B ) gal dcm (DE3) Invitrogen
LIX11 H37Rv DpknK This study
LIX16 LIX11::pYA1580 This study
Plasmids
pGEM-T Easy Amp
R, TA cloning vector for PCR products Promega
pET SUMO Kan
R, 6xHis-SUMO expression vector Invitrogen
pYUB854 Hyg
R, cosmid vector used in construction of the phasmid
carrying the allelic-exchange substrate
Bardarov et al. (2002)
pMV306 Kan
R, mycobacterial integrating vector Stover et al. (1991)
pSH276 Rv0195 gene in pQE40
DDHFR Haydel & Clark-Curtiss (2004)
pSH337 clpC gene in pGEM-T Haydel & Clark-Curtiss (2004)
pSH317 devR gene in pQE40
DDHFR Haydel & Clark-Curtiss (2004)
pSH281 Rv2027c gene in pQE40
DDHFR Haydel & Clark-Curtiss (2004)
pSH334 regX3 gene in pZERO/Km Haydel & Clark-Curtiss (2004)
pYA1620 pknA gene (C-term) in pGEM-T Easy This study
pYA1537 pknB gene in pGEM-T Easy This study
pYA1538 pknD gene in pGEM-T Easy This study
pYA1539 pknE gene in pGEM-T Easy This study
pYA1540 pknF gene in pGEM-T Easy This study
pYA1541 pknG gene in pGEM-T Easy This study
pYA1621 pknH gene (N-term) in pGEM-T Easy This study
pYA1542 pknI gene in pGEM-T Easy This study
pYA1543 pknJ gene in pGEM-T Easy This study
pYA1544 pknK gene (N-term) in pGEM-T Easy This study
pYA1545 pknK gene (C-term) in pGEM-T Easy This study
pYA1546 pknL gene in pGEM-T Easy This study
pYA1556 Full-length pknK gene in pET SUMO This study
pYA1619 39 and 59 flanking regions of pknK gene cloned in the multiple
cloning sites of pYUB854
This study
pYA1580 pknK gene+300 bp upstream region cloned in XbaI/HindIII sites in pMV306 This study
*ATCC no. 25618, American Type Culture Collection.
DATCC no. 25177, obtained from Dr Richard F. Silver, Case Western Reserve University, OH, USA.
dDr William R. Jacobs, Jr, Albert Einstein College of Medicine, NY, USA.
§Dr Herbert Boyer, University of California, San Francisco, CA, USA.
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system as previously described (Bardarov et al., 2002). The 59 and 39
flanking regions of the pknK gene were amplified and cloned into
pYUB854 (Bardarov et al., 2002) to create pYA1619. pYA1619 and
phAE87 phage DNA were digested with PacI, ligated and packaged
using a lGigaPack III packaging extract (Stratagene) followed by
transduction into E. coli HB101. The phasmid DNA from the
transductants was electroporated into M. smegmatis mc
2155 and
plated for mycobacteriophage plaques at 30 uC. A high-titre phage
lysate, prepared from one temperature-sensitive phage plaque, was
used to infect H37Rv as described previously (Bardarov et al., 2002).
Hygromycin-resistant colonies were selected and confirmed by
Southern hybridization. The resulting H37Rv DpknK mutant strain
was designated LIX11. For complementation of the mutant, the pknK
gene plus the 300 bp upstream sequence, containing the putative
pknK promoter region, was cloned into the integrating vector
pMV306 (Stover et al., 1991) to generate pYA1580 and electroporated
into LIX11 electrocompetent cells. The complemented strain was
designated LIX16.
Electron microscopy. For scanning electron microscopy (SEM),
colonies of M. tuberculosis H37Rv and LIX11 from Middlebrook
7H10 agar plates were fixed (2% glutaraldehyde in 0.1 M sodium
phosphate buffer, pH 7.2), washed and treated with 1% osmium
tetroxide. The cells were dehydrated in acetone and coated with gold
before scanning by a 360FE scanning electron microscope (Leica-
Cambridge) at 10 kV accelerating voltage. The cells were measured
using the software EDS 2006 (IXRF Systems). At least 75 measure-
ments in different samples were made to determine the size of the
respective bacilli; means±SE were calculated. For transmission
electron microscopy (TEM), cells from exponential-phase cultures
of wild-type H37Rv and LIX11, from two independent experiments,
were fixed with glutaraldehyde, embedded in Spurr’s epoxy resin
according to standard microscopy methods and stained with 1%
aqueous uranyl acetate and lead citrate before observation under a
Philips CM12 transmission electron microscope.
In vitro growth determinations. For comparison of the in vitro
growth rates, wild-type H37Rv, and strains LIX11 and LIX16, were
cultured aerobically at 37 uC and growth was monitored in 7H9-Tw-
ADS medium for 30 days, in acid/oxidative stress medium for 5 days
or in sealed tubes for 20 days (in the case of hypoxia). Serial dilutions
of the cultures at various time points were plated on Middlebrook
7H10 agar plates and incubated at 37 uC for 3 weeks before
quantification of c.f.u.
Low-dose-aerosol mouse infection studies. All animal experi-
ments and procedures were conducted according to protocols
approved by the Arizona State University Institutional Animal Care
and Use Committee. Mycobacterial stocks for infection were cultured
in 7H9-Tw-ADS medium and quantified by assessment of c.f.u. prior
to infection. For preparation of the inoculum, each stock was passed
through a 30G needle at least 10 times to obtain a single-cell
suspension. Bacterial suspensions of strains H37Rv, LIX11 and LIX16
thus prepared were diluted in PBS and used to infect 6- to 8-week old
female C57BL/6 mice (Charles River laboratories) with ~100–200
c.f.u./lung. Aerosol infections were performed essentially as described
previously (Kelly et al., 1996), using a Glas-Col Airborne infection
apparatus. In two separate, but identically conducted, experiments,
growth of M. tuberculosis strains was monitored from day 1 to 4 weeks
post-infection (acute phase, experiment 1) and between 4 and 12
weeks (chronic phase, experiment 2). At day 1 post-infection, lung
tissues were collected from two mice in each group to verify the exact
infectious dose. At specific time points, five animals per strain were
euthanized by carbon dioxide asphyxiation to assess growth and
survival of M. tuberculosis strains during infection in lungs and
spleens. The cardiac lobe of the lungs was dissected, kept in RNAlater
(Ambion) at 4 uC for subsequent RNA extraction and the remaining
lung was homogenized and assessed for c.f.u.
Cytokine measurement in lung tissues. Lung tissues from four
mice infected with the wild-type or the LIX11 mutant were pooled and
processedforRNAisolationasdescribedbyMalhotra et al. (2009). Total
RNA (1 mg) was converted to cDNA and real-time PCR with SYBR
green was used to measure the expression of interleukin (IL)-12p40,
tumour necrosis factor (TNF)-a, interferon (IFN)-c and inducible nitric
oxide synthase (iNOS) using primer sequences and parameters as
described previously (Gonzales & Orlando, 2008; Overbergh et al.,
1999). b-ActinmRNAwasusedasaninternalnormalizationcontroland
fold change of the transcripts in LIX11-infected mice was determined
relative to the expression in H37Rv-infected mice.
In vitro and in vivo localization of PknK in M. tuberculosis.
PknK localization was determined in vitro by Western blot analysis of
the whole-cell lysate and the cell wall, cell membrane, culture filtrate,
cytosolic and soluble cell wall protein fractions of M. tuberculosis. In
vivo localization of PknK was done using immunoelectron micro-
scopy (IEM). Peripheral blood was obtained from healthy human
subjects specifically for research. This research was conducted
according to a protocol approved by the Institutional Review Board
of Arizona State University and permission was granted by all
subjects. Human macrophage infections were performed as described
elsewhere (Graham & Clark-Curtiss, 1999; Hou et al., 2002), except
that macrophages were grown attached to Thermanox coverslips
(Nunc) and association with bacteria was allowed for 4 h. On day 1
post-infection, cells on the coverslips were fixed with 2% para-
formaldehyde and 0.5% glutaraldehyde in 0.1 M sodium phosphate
buffer (pH 7.2) and prepared for electron microscopy as described
previously (Dasgupta et al., 2000). For immunolabelling, the sections
were blocked in buffer [0.1 M sodium phosphate (pH 7.0), 0.15 M
sodium chloride and 1% BSA], followed by incubation with anti-
PknK antibody (1:20) overnight at 4 uC. After washing, the grids
were incubated with anti-rabbit IgG conjugated to 20 nm gold
particles (1:100; MP Biomedical) and stained for TEM.
Statistical analysis. Statistical analyses were done using two-way
ANOVA with Bonferroni post-tests whereever applicable. Significance
of differences between the mutant and wild-type bacilli in animal
studies was assessed by Student’s t-test. All tests were done using
GraphPad Prism 5.0 software. Differences with a P-value ,0.05 were
considered significant.
RESULTS
Expression profiling of M. tuberculosis STPK
genes in culture and during infection in human
macrophages
Using qRT-PCR, we analysed the differential expression of
STPK genes in exponential-phase cultures of H37Rv and
H37Ra. The basal level of expression of STPK genes in
H37Rv and H37Ra is shown in Supplementary Fig. S1. For
each gene, the ratio of its expression in H37Rv versus
H37Ra was calculated and is listed in Table 2. Six STPK
genes (pknD, pknG, pknH, pknJ, pknK and pknL) were
expressed at higher levels (ratio .1) in H37Rv compared
to H37Ra, with the difference being significant (P,0.01)
for pknD, pknK and pknL (Table 2, bold type).
Given the limitations in obtaining considerable amounts of
both human macrophages and bacterial RNA from infected
V. Malhotra and others
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in human macrophages was done using SCOTS-purified
cDNA probes, previously made in our laboratory from
H37Rv-infected macrophages at 18 h, 48 h and 110 h post-
infection (Graham & Clark-Curtiss, 1999). As seen in Table
2, transcripts of all STPK genes except pknI were detected
during infection. Transcripts specific to pknB, pknD and
pknL were constitutively expressed at all time points
studied, while others exhibited differential expression.
The expression of clpC, Rv2027c, regX3, devR and Rv0195
served as controls as described previously (Haydel & Clark-
Curtiss, 2004) (data not shown). In Table 2, we have
compiled the SCOTS results for STPK genes with current
data on their expression in macrophages, and the lack of
information on STPK gene expression in macrophages is
strikingly evident. Based on the observations that pknK is
expressed at significantly higher levels in H37Rv compared
to H37Ra (Table 2, Supplementary Fig. S1, P,0.001) and
only at 18 h of infection in human macrophages (Table 2),
we hypothesized that PknK played a role in the early
establishment of infection in macrophages. Further char-
acterization of PknK was carried out to test this hypothesis.
Construction of DpknK and complemented
mutant strains of M. tuberculosis
We constructed an M. tuberculosis H37Rv DpknK strain,
designated here LIX11, through allelic exchange with a
hygromycin-resistance gene, using the specialized transdu-
cing mycobacteriophage system (Bardarov et al., 2002).
The genome organization of pknK (Rv3080c), its adjacent
genes in the H37Rv chromosome and the changes in the
mutant strain are illustrated in Fig. 1(a). The hygromycin-
resistance cassette flanked by res sites replaced the pknK
gene in a double-crossover event, resulting in complete
deletion of the pknK gene. The mutant was verified by
Southern hybridization using probes specific for the
hygromycin gene, the 39 flanking region of pknK and
pknK itself (Fig. 1b). Allelic exchange in LIX11 was
confirmed by the absence or presence of a hybridization
signal with pknK- and hyg-specific probes, respectively (Fig.
1b). Deletion of pknK in LIX11 was complemented by
transforming the mutant with pYA1580, which provides a
single functional copy of pknK transcribed from a putative
pknK promoter to generate the complemented strain
LIX16. Western blot analysis confirmed the absence of a
band corresponding to PknK in the LIX11 mutant (Fig. 1c,
lane 2) and its presence in the wild-type and complemen-
ted mutant strains (Fig. 1c; lanes 1 and 3, respectively). The
blot was stained with Ponceau S in order to confirm that an
equal amount of protein was loaded and that the protein
had not degraded (data not shown).
Deletion of pknK affects cell size and cell wall
composition
The morphology of broth-grown wild-type and mutant
bacilli was compared by SEM and TEM. Although no
Table 2. M. tuberculosis STPK gene expression in virulent and avirulent strains during exponential growth and in H37Rv-infected
human macrophages, and published data on expression in macrophages
The six STPK genes (pknD, pknG, pknH, pknJ, pknK and pknL) that were expressed at higher levels (ratio .1) in H37Rv compared with H37Ra are
shown in bold type.
Rv no. Gene Expression in
broth cultures by
qRT-PCR
H37Rv/H37Ra*
Expression in H37Rv-infected human
PBMC-derived macrophages,
determined by SCOTSD at:
Expression during growth in macrophages
(published data)d
18 h 48 h 110 h
Rv0015c pknA 0.82 + 22 Upregulation in THP1 cells (Singh et al., 2006)
Rv0014c pknB 0.76 ++++ ++++ ++++ Constitutive expression in murine alveolar and THP1
macrophages (Av-Gay et al., 1999; Singh et al., 2006)
Rv0931c pknD 2.4 (P,0.001) +++ ++++ +++ ND
Rv1743 pknE 0.9 +++ 22 ND
Rv1746 pknF 0.71 ++++ 2 ++++ ND
Rv0410c pknG 1.27 ” ++++ ++++ ND
Rv1266c pknH 1.2 ” + ” ND
Rv2914c pknI 0.72 22 2 Decreased expression in THP1 cells (Singh et al., 2006)
Rv2088 pknJ 1.1 + ”” ND
Rv3080c pknK 1.5 (P,0.001) ++++ ”” ND
Rv2176 pknL 1.6 (P,0.01) ++++ ++++ +++ ND
*Expressed as a ratio of H37Rv/H37Ra. P-values are given where difference is significant.
DExpression of genes was designated low (+), moderate (++/+++) or high (++++), based on intensity values. 2, No expression.
dND, No data.
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media, SEM analyses revealed that the mutant bacilli were
significantly smaller in length (1.7±0.034 mm, n575;
P,0.001) compared to the wild-type (2.3±0.064 mm,
n575; n refers to the number of independent measure-
ments). TEM cross-sections of exponentially grown wild-
type and mutant cells were similar, except for the dense
staining and contrast that was observed associated with the
cell wall of wild-type cells but was absent in a majority of
the mutant cells (arrows, Fig. 2). These results suggest that
PknK function may affect cell size and cell wall composi-
tion in M. tuberculosis.
PknK slows the growth of M. tuberculosis during
stationary phase
The growth characteristics of strains H37Rv, LIX11 and
LIX16 were analysed by measuring viable cell counts
during growth in broth cultures over a period of 30 days.
All three strains grew similarly during the exponential
phase; however, a significant increase in c.f.u. of the
mutant bacilli was observed from day 10 onwards. At day
15, a 3.6-fold increase (P,0.001) in viable counts was
determined for LIX11 compared to H37Rv (Fig. 3a). It
appears that while the wild-type entered into stationary
phase between days 5 and 10 and maintained a steady level
of c.f.u. for the next 10 days, strain LIX11 did not show a
typical entry into stationary phase, but continued to grow
and maintained higher c.f.u. consistently through days 10
to 30 (Fig. 3a). The growth of LIX16 was similar to that of
H37Rv, indicating that the phenotype of LIX11 was indeed
due to the deletion of pknK. To correlate PknK production
as a function of growth of H37Rv, we determined PknK
levels by Western blot analysis of H37Rv cell lysates
prepared from samples at days 3 and 30, representing
exponential and late stationary phases, respectively. Equal
amounts of total protein from day 3 and day 30 lysates, as
seen in the Ponceau S stained blot (Fig. 3b, lanes 1 and 2,
Fig. 1. Construction of an M. tuberculosis
DpknK strain by allelic replacement. (a)
Schematic representation of the chromosomal
locus of pknK and its adjacent genes in the
wild-type H37Rv and the LIX11 mutant strain,
in which the pknK gene is deleted and
replaced with a hygromycin-resistance cas-
sette. The striped bars indicate the position of
the DNA probes used for Southern blot
analysis and the dashed lines indicate the
expected size of the hybridization with the
specific probes. (b) Southern blot confirmation
of the LIX11 mutant strain. Chromosomal DNA
was isolated from strains H37Rv (lane 1) and
LIX11 (lane 2), digested with HindIII and
hybridized with probes specific for the hyg,
pknK and 39 flank regions. (c) Western blot
analysis of PknK (~119 kDa, arrow) in the
whole-cell lysates of M. tuberculosis H37Rv
(lane 1), LIX11 mutant (lane 2) and LIX16
complemented mutant (lane 3) strains. M,
molecular size markers.
Fig. 2. TEM analysis of M. tuberculosis
H37Rv (a) and the LIX11 mutant strain (b),
showing differences in the staining pattern of
the cell wall. Wild-type H37Rv and the LIX11
mutant were cultivated in Middlebrook 7H9-
Tw-ADS medium to exponential phase (OD600
0.3–0.4) and processed for electron micro-
scopy in two separate experiments. One
representative picture is shown. Scale bars,
0.2 mm. Arrows indicate dense granular stain-
ing present in the cell wall of the wild-type, but
absent in LIX11.
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PknK was significantly induced in lysates from late
stationary phase (Fig. 3b, lane 4) compared to exponential
phase (Fig. 3b, lane 3). It is apparent from these
observations that induced levels of PknK in stationary
phase either directly or indirectly activate cellular targets or
pathways that slow the growth of mycobacteria.
Based on these results, we also investigated growth and
survival of M. tuberculosis strains H37Rv, LIX11 and
LIX16 under in vitro stress conditions: acidic (pH 5.5),
oxidative (5 mM hydrogen peroxide) and hypoxia
(Supplementary Fig. S2). By day 5, LIX11 was signific-
antly resistant, compared to wild-type H37Rv, in terms
of c.f.u., to acidic pH (3.58-fold; P,0.05), 5 mM
hydrogen peroxide (6.48-fold; P,0.001), and hypoxia
(3.0-fold; P,0.001) (Supplementary Fig. S2). Though
the fold changes seem modest, the increased resistance of
the mutant to stress conditions examined in this study,
including stationary-phase stress (Fig. 3a), was statist-
ically significant and was obtained consistently over three
independent experiments. The reversion of the pheno-
type to wild-type levels upon complementation of the
mutant further supports our observations. Together,
these results suggest a role for PknK in the regulation of
cellular events that promote bacterial adaptation to
environmental changes, a function that may be critical to
survival in vivo.
Roles of PknK during acute and persistent
M. tuberculosis infection in mice
The relevance of PknK-mediated growth adaptation was
evaluated in individual low-dose aerosol infections with
strains H37Rv, LIX11 and LIX16 in C57BL/6 mice.
Growth was measured between day 1 (deposition) and
week 4 (peak of acute phase), and between weeks 4 and
12 (chronic phase) in two separate experiments. During
the acute phase of infection, the intracellular growth of
LIX11 was significantly inhibited at 1 week post-infection
in mouse lungs by ~16.5-fold (P,0.001) compared to
H37Rv or LIX16 (Fig. 4a). However, by week 4, all three
strains reached similar c.f.u. levels, indicating a function
for PknK during early adaptive events in the host. To
assess whether the lag in the growth of LIX11 at week 1
post-infection was due to inherent reduced infectivity of
the mutant, we analysed uptake and intracellular growth
of all three strains in an in vitro model of infection using
human macrophages. No differences were observed
between the three strains in their abilities to infect and
survive in the macrophages (data not shown), suggesting
that the phenotype of LIX11 in mice was specifically
due to an effect of the in vivo environment. We also
monitored the total body weight of infected animals as
an index of inflammation and pathology. Mice infected
with LIX11 exhibited a significant increase in gross body
weights compared to the wild-type at both week 1 (5%)
and week 2 post-infection (10%, P,0.001), but by week
3, all animals had similar weights (Fig. 4b). The ability of
all the strains to disseminate to spleens was similar and
occurred by week 2. Although spleens infected with
LIX11 exhibited higher inflammation at week 3 post-
infection (Fig. 4c), no differences in the viable counts of
the three strains were detected in the spleens (data not
shown). Thus, a defect during early growth in lungs
specifically at week 1 and increased inflammation were
the hallmarks of acute infection with the M. tuberculosis
DpknK strain.
Fig. 3. Effect of pknK deletion on growth of M. tuberculosis in culture. (a) Aerobic growth of H37Rv wild-type, LIX11 mutant
and LIX16 complemented strain in 7H9-Tw-ADS medium was monitored for 30 days by measuring viable cell counts. The
results presented are the mean±SD from three independent growth experiments. ** and *** represent P,0.01 and P,0.001,
respectively, for the differences between the mutant and wild-type strain at a particular time point. Arrows indicate the time
points, representing exponential phase (day 3) and late stationary phase (day 30), respectively, during growth at which samples
were taken and analysed for PknK protein levels. (b) Western blot analysis of PknK protein in H37Rv cell lysates at days 3 and
30. The Ponceau S stained blot shows equal loading of total protein from day 3 and 30 samples (lanes 1 and 2, respectively).
PknK production is induced in stationary phase (lane 4) compared to exponential phase (lane 3). M, molecular size markers.
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lungs for 4 weeks as in experiment 1 (Fig. 4a), after which
the c.f.u. levels decreased and stabilized, indicating a
chronic or persistent infection (Fig. 4d). Approximately
5.3- and 4.8-fold higher c.f.u. (P,0.01) were recovered
from LIX11-infected mice at 5 and 8 weeks post-infection,
respectively, than from mice infected with H37Rv (Fig. 4d).
In spleens, a similar increase of 3.56-fold (P,0.01) in
viable counts of the mutant strain was observed at 8 weeks
post-infection (Fig. 4e). In both experiments, the LIX16
complemented strain was able to restore the parental
phenotype. Reproducible results from a third experiment,
wherein c.f.u. levels were measured at weeks 1, 2, 3, 4 and 8
weeks post-infection, further confirmed our observations
(data not shown). Collectively, these results indicate that
PknK is required during early stages of infection in lungs
and modulates the intracellular survival of mycobacteria
during the chronic phase of infection in both lungs and
spleens.
PknK modulates host immune effectors during
early infection
To decipher the role of PknK in early infection events, we
compared the mRNA levels of key pro-inflammatory
cytokines, IL-12p40, TNF-a,I F N - c and iNOS, by qRT-
PCR over 3 weeks in lung tissues pooled from groups of
four mice infected with the wild-type or mutant strain.
Transcript levels of TNF-a were twofold higher (P,0.001)
at week 1 post-infection in LIX11-infected mice compared
to the wild-type-infected mice (Fig. 5). In contrast,
expression of IL-12p40, a key effector of Th1-mediated
immunity, was 1.66-fold lower (P,0.01) in LIX11-
infected mice (Fig. 5). At week 2, LIX11-infected mice
were unable to elicit induction of IL-12p40, TNF-a, IFN-c
and iNOS to levels comparable to those obtained in
H37Rv-infected mice (Fig. 5). In fact, the levels of IL-
12p40, IFN-c and iNOS were significantly repressed, by
1.47-, 3.6- and 3.4-fold, respectively, in the tissues from
LIX11-infected mice (Fig. 5, P,0.01). By week 3, the
expression levels of all genes except TNF-a were still lower
in the LIX11-infected than in the H37Rv-infected mice;
however, these differences were not significant. We also
analysed cytokine levels in LIX16-infected animals and
observed complementation only at week 1 post-infection
(data not shown).We attribute the lack of complementa-
tion at other time points to possible pleiotropic effects of
PknK deletion. These data suggest an immunomodulatory
function of PknK during establishment of acute infection
in mice.
Fig. 4. Growth and survival of M. tuberculosis
strains H37Rv, LIX11 and LIX16 in immuno-
competent mice. Virulence of the wild-type,
LIX11 and LIX16 strains was assessed in
aerosol-infected C57BL/6 mice during the
acute phase of infection (experiment 1; day 1
through 4 weeks). (a) Viable counts in lungs.
For the sake of clarity, day 1 c.f.u. levels are
plotted as time50. (b) Increase in gross body
weight over time. Statistical differences
between LIX11 versus wild-type or LIX16
strains at week 2 post-infection are shown. **
and *** denote P,0.01 and P,0.001 respect-
ively. (c) Spleen inflammation observed at 3
weeks post-infection with all three strains. One
representative picture is shown. (d, e) Growth
during the chronic phase of infection (experi-
ment 2; 4 to 12 weeks) was assessed by
viable counts in lungs (d) and in spleens (e).
Note that the initial day 1 c.f.u. levels were
similar in both experiments. Data presented are
the mean c.f.u. (±SD) obtained from five mice
per group. ** and *** represent P,0.01 and
P,0.001, respectively, for the differences in
the growth of LIX11 compared to H37Rv in the
lungs and spleens of infected animals.
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membrane components and may be secreted
during infection
Based on our results implicating PknK in the regulation of
M. tuberculosis growth and modulation of host immunity in
vivo, we investigated the location of PknK in M. tuberculosis
in vitro and within infected macrophages. Immunoblot
analyses of subcellular fractions of M. tuberculosis revealed
the presence of PknK in the cell wall and cell membrane
fraction; however, the signal was very faint in the latter
(Fig. 6a, lanes 3 and 4). We also detected the presence of
PknK in the soluble cell wall fraction (Fig. 6a, lane 7), which
contains soluble proteins typically associated with cell wall/
membrane components. In vivo localization of PknK was
observed by IEM. At day 1 post-infection, M. tuberculosis
was visualized within phagocytic vacuoles inside infected
macrophages. Although the overall labelling for PknK was
low, gold particles were observed associated with cell walls
of M. tuberculosis residing within the phagosomes inside the
macrophage (Fig. 6b). Interestingly, we alsoobserved PknK-
specific labelling in the lumen of the phagosome. Because of
the low signal, the experiment was repeated and observa-
tions over several sections revealed reproducible results. No
labelling was noted either with uninfected macrophages or
with infected macrophages not treated with anti-PknK
antibody, indicating the specificity of the labelling (data
not shown). These findings indicate that PknK is
synthesized by M. tuberculosis in the phagosomal envir-
onment of human macrophages, is located in the bacterial
cell wall and may also be secreted into the phagosomal
lumen.
DISCUSSION
Protein kinase K is one of the largest, multi-domain STPK
proteins annotated as a transcriptional regulator (Av-Gay
& Everett, 2000). Besides its recent association with the
transcriptional regulation of the mycobacterial monoox-
ygenase (mymA) operon of M. tuberculosis (Kumar et al.,
2009), little is known about the function of PknK in
mycobacterial growth, physiology and virulence. In the
present report, we have established a role for PknK in the
pathogenesis of M. tuberculosis. Our results implicate PknK
in the regulatory mechanisms that modulate the growth of
M. tuberculosis in culture and during persistent infection in
mice. We also show that PknK functions as a modulator
of host immunity that is accompanied by positive or
negative effects on M. tuberculosis growth during early and
late stages of infection, respectively, in immunocompetent
mice.
Fig. 5. Role of PknK in modulation of host immunity. The IL-
12p40, TNF-a, IFN-c and iNOS mRNA levels in mice infected with
LIX11 or H37Rv were determined by qRT-PCR over 3 weeks
post-infection in RNA extracted from lung tissues pooled from four
infected mice in each group. Normalization of expression was done
with b-actin mRNA. qRT-PCR analysis was done in triplicate and
data are presented as means±SD from at least two independent
cDNA preparations. ** and *** denote P,0.01 and P,0.001,
respectively, for the differences in the expression of IL-12p40,
TNF-a, IFN-c and iNOS in the mutant-infected animals versus the
H37Rv-infected mice at a given time point.
Fig. 6. PknK localization in broth cultures and within infected macrophages. (a) Western blot analyses of the whole-cell lysate
(lane 2), and the cell wall (lane 3), cell membrane (lane 4), culture filtrate (lane 5), cytosolic (lane 6) and soluble cell wall
fractions (lane 7) of M. tuberculosis with anti-PknK antibody. Purified full-length, 6xHis-SUMO-tagged PknK recombinant
protein (~130 kDa) was used as a positive control (lane 1). The presence of native M. tuberculosis PknK (~119 kDa) is
indicated by an arrow. (b) Immunolocalization of PknK within infected human macrophages at day 1 post-infection (bars,
0.2 mm). Arrows indicate PknK-specific labelling on the cell wall of M. tuberculosis (Mtb) and also within the phagocytic vacuole
(phagosome). Two representative pictures are presented.
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virulence factors through a screening approach based on
the differential expression of STPK genes in broth-grown
cultures of H37Rv and H37Ra, and in H37Rv-infected
human macrophages. Extending the rationale that has led
to the successful identification of virulence factors in the
past (Sharma & Tyagi, 2007), we reasoned that STPK genes
having higher expression in H37Rv compared to H37Ra
could be associated with functions critical to pathogenicity.
In the second screen, we used SCOTS-generated cDNA
mixtures to analyse STPK gene expression in H37Rv-
infected human macrophages. Although quantitative esti-
mations were not possible by this approach, it provided
useful insights into the temporal expression of STPK genes
during infection and correlated with the available data for
most of the genes. For example, PknL has been grouped
with PknA/PknB and is implicated in the regulation of
cell shape and cell division (Narayan et al., 2007). The
constitutive expression of pknL and pknB in H37Rv-
infected human macrophages (Table 2) supports this
hypothesis and exemplifies the robustness of the screen.
Absence of pknI transcripts in our experiments could be
due to the limit of detection since pknI expression
decreases during infection in THP1 cells (Singh et al.,
2006). Results from both screens highlighted pknK among
STPK genes that were significantly expressed in H37Rv
compared to H37Ra and during early time points of
infection in human macrophages (Table 2). These data
provided the impetus to investigate the role of PknK in
mycobacterial pathobiology.
To address these questions, we constructed and character-
ized LIX11, a DpknK strain of H37Rv. Surprisingly,
deletion of pknK affected physical attributes like cell size
and the cell wall ultrastructure of the bacilli. These
observations, particularly the perturbations in the cell wall,
provide some insights into the target proteins of PknK.
PknK is known to phosphorylate VirS and several members
of the mymA operon of M. tuberculosis (Kumar et al.,
2009). Interestingly, proteins encoded by the mymA operon
are involved in the biosynthesis of mycolic acids, essential
components of the mycobacterial cell wall that are also
immunogenic (Korf et al., 2005). It is thus plausible that
the aberrant synthesis of these key molecules or down-
stream modified lipids in LIX11 is responsible for the
differential cell wall staining patterns compared to the
wild-type. Our interpretations are supported by previous
findings demonstrating a requirement of mymA operon in
the maintenance of cell wall structure and in persistent
infection in guinea pigs (Singh et al., 2003, 2005).
The LIX11 mutant is phenotypically different from the
parent strain in terms of its growth and survival in vitro
and in vivo. The most striking feature of the growth of
LIX11 in broth cultures is its increased survival during
stationary phase (Fig. 3a). In addition, increased resistance
of the mutant to specific stresses, acidic pH, oxidative stress
and hypoxia (Supplementary Fig. S2), provides evidence
for PknK-mediated mechanisms that regulate growth
under stress conditions and suggests a link between PknK
function and energy status, catabolic activity, and/or the
environment of the bacterial cell. Contrary to in vitro
growth, the dynamics of M. tuberculosis growth in vivo are
governed by combined effects of the pathogen and the host.
We investigated the virulence of LIX11 in C57BL/6 mice
using the low-dose aerosol model of infection, wherein
unrestricted growth of M. tuberculosis occurred during the
acute infection, after which the viable counts decreased and
stabilized, characteristic of a chronic or persistent infection
(Kelly et al., 1996). The transition from acute to chronic
phase is marked by the reduced transcriptional activity of
M. tuberculosis genes and decrease in growth (Shi et al.,
2003; Talaat et al., 2007). The increase in the viable counts
of the mutant during the chronic phase of infection
(Fig. 4d, e) suggests involvement of PknK in such growth
adaptive events. A common theme that is evident from our
in vitro and in vivo studies is the role of PknK in slowing
the growth of M. tuberculosis during stress conditions in
culture and during chronic infection. It is of note that the
deletion of pknH (Papavinasasundaram et al., 2005) and
pknI (Gopalaswamy et al., 2009) also resulted in increased
bacillary loads during persistent infection in mice. Al-
though very little is known about the persistent phase, it is
apparent that M. tuberculosis possesses distinct regulatory
mechanisms that enable the switch between fast and slow
growth rates (Beste et al., 2007, 2009) and, importantly,
STPKs seem to be integral to these strategies.
PknK is the fourth STPK implicated in mycobacterial
pathogenesis, but it is the first one shown to play a role in
early infection events. Although the molecular events that
lead to the early establishment of tuberculosis infection are
not well understood, evidence suggests that M. tuberculosis
alters macrophage signalling for the production of
cytokines and effector molecules (Beltan et al., 2000;
Falcone et al., 1994). We show that PknK modulates the
host immune response as early as 1 week post-infection.
Absence of PknK in LIX11 resulted in the upregulation of
TNF-a, a key pro-inflammatory cytokine with anti-
mycobacterial effects (Fig. 5). Most importantly, TNF-a
induction coincided with the inhibition of growth of the
mutant at 1 week post-infection (Fig. 4a) and correlated
with the exaggerated inflammatory response in LIX11-
infected mice (Fig. 4b, c). It is plausible that in the wild-
type H37Rv, PknK plays a direct or indirect role in
immune suppression, thus enabling exponential growth by
providing a survival advantage to the wild-type during
early stages of infection. It is established that IL-12p40
induces production of IFN-c, a key Th1 cytokine (Magram
et al., 1996); hence in view of the downregulation of IL-
12p40 mRNA levels in LIX11-infected mice at 1 and 2
weeks post-infection, it is not surprising that the LIX11
mutant failed to induce IFN-c at 2 weeks post-infection
to the levels observed in H37Rv-infected mice (Fig. 5).
Together, IL-12p40 (Cooper et al., 1997), IFN-c (Flynn
et al., 1993) and iNOS (MacMicking et al., 1997) are
known to play protective roles in murine tuberculosis
V. Malhotra and others
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three to four) (Shi et al., 2003). Thus their downregulation
may be a prime factor contributing to the increased
bacillary load of the mutant observed in the lungs and in
spleens of mice during the persistent phase of infection.
These results are indicative of distinct roles of PknK in
responding to the intracellular environment. Specifically,
the ability of PknK to subvert the immune response to
facilitate exponential growth of mycobacteria during the
acute phase of infection is intriguing and brings forth
questions regarding the localization of PknK in vivo and
possible cross-talk with eukaryotic signalling pathways.
Although the localization of PknK in subcellular fractions
of M. tuberculosis has been recently reported (Kumar et al.,
2009), we revisited this question, both in vitro and in vivo.
Our results with broth-grown M. tuberculosis confirm their
observations and add that PknK is a soluble protein
associated with the proteins and/or lipids in the cell wall/
membrane of M. tuberculosis (Fig. 6a). In view of the faint
band in the cell membrane fraction (Fig. 6a; lane 4), it is
likely that the association of PknK with the cell membrane
is transient, but this result provides a clue to PknK function
in signalling events or metabolite transport that may occur
at these sites. Interaction of PknK with inner-membrane
ABC transporters has been speculated through in silico
studies (Cui et al., 2009). A similar localization of PknK in
M. tuberculosis cells residing within the phagosome and, in
addition, a consistent but low level of PknK-specific
labelling in the phagosomal space, suggests that PknK is
capable of sensing the intracellular environment cues and
may also be secreted into the phagosomal compartment
(Fig. 6b). One of the limitations of EM studies is the
destruction of antigen due to chemical treatments;
however, low levels of PknK cannot be excluded. Al-
though PknK does not have a typical signal sequence,
secretion could occur through alternative secretion path-
ways as seen in the case of PknG (Walburger et al., 2004).
Nevertheless, in view of PknK’s function in early infection
and immune modulation, such a possibility warrants
further exploration, and undoubtedly will have significant
implications in host–pathogen interactions, particularly
regarding the signalling pathways governing the early
events of infection. These findings open exciting avenues
for future research to address critical questions on
strategies employed by mycobacteria to enable survival
and the early establishment of infection in the host.
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